Presynaptic alpha-synuclein aggregation in a mouse model of Parkinson's disease

Journal of Neuroscience

Volumn 34, Issue 6, 2014, Pages 2037-2050

  Spinelli, Kateri J ^a   Taylor, Jonathan K ^a   Osterberg, Valerie R ^a   Churchill, Madeline J ^b   Pollock, Eden ^b   Moore, Cynthia ^b   Meshul, Charles K ^a,b   Unni, Vivek K ^a,c  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b PORTLAND VA MEDICAL CENTER   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; PROTEINASE K; SYNAPSIN;

ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ELECTRON MICROSCOPY; FEMALE; FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING; IMMUNOGOLD ELECTRON MICROSCOPY; IMMUNOHISTOCHEMISTRY; MOUSE; MULTIPHOTON MICROSCOPY; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN DEGRADATION; SYNAPTOSOME; WESTERN BLOTTING;

ALPHA-SYNUCLEIN; ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING; HUMANS; MALE; MICE; MICE, TRANSGENIC; PARKINSON DISEASE; PRESYNAPTIC TERMINALS;

EID: 84893488562     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.2581-13.2014     Document Type: Article

References (80)

1. Adalbert R, Coleman MP (2012) Axon pathology in age-related neurodegenerative disorders. Neuropathol Appl Neurobiol.
2. Arima K, Uéda K, Sunohara N, Hirai S, Izumiyama Y, Tonozuka-Uehara H, Kawai M (1998) Immunoelectron-microscopic demonstration of NACP/ alpha-synuclein-epitopes on the filamentous component of Lewy bodies in Parkinson's disease and in dementia with Lewy bodies. Brain Res 808: 93-100. CrossRef Medline
3. Arrio-Dupont M, Foucault G, Vacher M, Devaux PF, Cribier S (2000) Translational diffusion of globular proteins in the cytoplasm of cultured muscle cells. Biophys J 78: 901-907. CrossRef Medline
4. Bamford NS, Robinson S, Palmiter RD, Joyce JA, Moore C, Meshul CK (2004) Dopamine modulates release from corticostriatal terminals. J Neurosci 24: 9541-9552. CrossRef Medline
5. Bartels T, Choi JG, Selkoe DJ (2011) Alpha-synuclein occurs physiologically as a helically folded tetramer that resists aggregation. Nature 477: 107-110. CrossRef Medline
6. Betarbet R, Sherer TB, MacKenzie G, Garcia-Osuna M, Panov AV, Greenamyre JT (2000) Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat Neurosci 3: 1301-1306. CrossRef Medline
7. Bodner RA, Housman DE, Kazantsev AG (2006) New directions for neurodegenerative disease therapy: using chemical compounds to boost the formation of mutant protein inclusions. Cell Cycle 5: 1477-1480. CrossRef Medline
8. Brown EB, Wu ES, Zipfel W, Webb WW (1999) Measurement of molecular diffusion in solution by multiphoton fluorescence photobleaching recovery. Biophys J 77: 2837-2849. CrossRef Medline
9. Chartier-Harlin MC, Kachergus J, Roumier C, Mouroux V, Douay X, Lincoln S, Levecque C, Larvor L, Andrieux J, Hulihan M, Waucquier N, Defebvre L, Amouyel P, Farrer M, Destée A (2004) Alpha-synuclein locus duplication as a cause of familial Parkinson's disease. Lancet 364: 1167-1169. CrossRef Medline
10. Conway KA, Harper JD, Lansbury PT (1998) Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease. Nat Med 4: 1318-1320. CrossRef Medline
11. Dale GE, Probst A, Luthert P, Martin J, Anderton BH, Leigh PN (1992) Relationships between Lewy bodies and pale bodies in Parkinson's disease. Acta Neuropathol 83: 525-529. CrossRef Medline
12. Davidson WS, Jonas A, Clayton DF, George JM (1998) Stabilization of alpha-synuclein secondary structure upon binding to synthetic membranes. J Biol Chem 273: 9443-9449. CrossRef Medline
13. Dettmer U, Newman AJ, Luth ES, Bartels T, Selkoe D (2013) In vivo crosslinking reveals principally oligomeric forms of alpha-synuclein and betasynuclein in neurons and non-neural cells. J Biol Chem 288: 6371-6385. CrossRef Medline
14. Emmer KL, Waxman EA, Covy JP, Giasson BI (2011) E46K human alphasynuclein transgenic mice develop Lewy-like and tau pathology associated with age-dependent, detrimental motor impairment. J Biol Chem 286: 35104-35118. CrossRef Medline
15. Farrer M, Kachergus J, Forno L, Lincoln S, Wang DS, Hulihan M, Maraganore D, Gwinn-Hardy K, Wszolek Z, Dickson D, Langston JW (2004) Comparison of kindreds with Parkinsonism and alpha-synuclein genomic multiplications. Ann Neurol 55: 174-179. CrossRef Medline
16. Fauvet B, Mbefo MK, Fares MB, Desobry C, Michael S, Ardah MT, Tsika E, Coune P, Prudent M, Lion N, Eliezer D, Moore DJ, Schneider B, Aebischer P, El-Agnaf OM, Masliah E, Lashuel HA (2012) Alpha-synuclein in central nervous system and from erythrocytes, mammalian cells, and Escherichia coli exists predominantly as disordered monomer. J Biol Chem 287: 15345-15364. CrossRef Medline
17. Ferris AM, Giberson RT, Sanders MA, Day JR (2009) Advanced laboratory techniques for sample processing and immunolabeling using microwave radiation. J Neurosci Methods 182: 157-164. CrossRef Medline
18. Flusberg BA, Cocker ED, Piyawattanametha W, Jung JC, Cheung EL, Schnitzer MJ (2005) Fiber-optic fluorescence imaging. Nat Methods 2: 941-950. CrossRef Medline
19. Fortin DL, Nemani VM, Voglmaier SM, Anthony MD, Ryan TA, Edwards RH (2005) Neural activity controls the synaptic accumulation of alphasynuclein. J Neurosci 25: 10913-10921. CrossRef Medline
20. Fujiwara H, Hasegawa M, Dohmae N, Kawashima A, Masliah E, Goldberg MS, Shen J, Takio K, Iwatsubo T (2002) Alpha-synuclein is phosphorylated in synucleinopathy lesions. Nat Cell Biol 4: 160-164. CrossRef Medline
21. Galvin JE, Uryu K, Lee VM, Trojanowski JQ (1999) Axon pathology in Parkinson's disease and Lewy body dementia hippocampus contains alpha-, beta-, and gamma-synuclein. Proc Natl Acad Sci U S A 96: 13450-13455. CrossRef Medline
22. Giasson BI, Duda JE, Murray IV, Chen Q, Souza JM, Hurtig HI, Ischiropoulos H, Trojanowski JQ, Lee VM (2000) Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions. Science 290: 985-989. CrossRef Medline
23. Giasson BI, Duda JE, Quinn SM, Zhang B, Trojanowski JQ, Lee VM (2002) Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein. Neuron 34: 521-533. CrossRef Medline
24. Goedert M (2001) Alpha-synuclein and neurodegenerative diseases. Nat Rev Neurosci 2: 492-501. CrossRef Medline
25. Gómez-Tortosa E, Newell K, Irizarry MC, Sanders JL, Hyman BT (2000) Alpha-synuclein immunoreactivity in dementia with Lewy bodies: Morphological staging and comparison with ubiquitin immunostaining. Acta Neuropathol 99: 352-357. CrossRef Medline
26. Hashimoto M, Hsu LJ, Xia Y, Takeda A, Sisk A, Sundsmo M, Masliah E (1999) Oxidative stress induces amyloid-like aggregate formation of NACP/alpha-synuclein in vitro. Neuroreport 10: 717-721. CrossRef Medline
27. Jiang M, Porat-Shliom Y, Pei Z, Cheng Y, Xiang L, Sommers K, Li Q, Gillardon F, Hengerer B, Berlinicke C, Smith WW, Zack DJ, Poirier MA, Ross CA, Duan W (2010) Baicalein reduces E46K alpha-synuclein aggregation in vitro and protects cells against E46K alpha-synuclein toxicity in cell models of familiar Parkinsonism. J Neurochem 114: 419-429. CrossRef Medline
28. Kramer ML, Schulz-Schaeffer WJ (2007) Presynaptic alpha-synuclein aggregates, not Lewy bodies, cause neurodegeneration in dementia with Lewy bodies. J Neurosci 27: 1405-1410. CrossRef Medline
29. Krüger R, Kuhn W, Müller T, Woitalla D, Graeber M, Kösel S, Przuntek H, Epplen JT, Schöls L, Riess O (1998) Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat Genet 18: 106-108. CrossRef Medline
30. Larson ME, Sherman MA, Greimel S, Kuskowski M, Schneider JA, Bennett DA, Lesné SE (2012) Soluble alpha-synuclein is a novel modulator of Alzheimer's disease pathophysiology. J Neurosci 32: 10253-10266. CrossRef Medline
31. Lippincott-Schwartz J, Snapp E, Kenworthy A (2001) Studying protein dynamics in living cells. Nat Rev Mol Cell Biol 2: 444-456. CrossRef Medline
32. Luk KC, Kehm VM, Zhang B, O'Brien P, Trojanowski JQ, Lee VM (2012) Intracerebral inoculation of pathological alpha-synuclein initiates a rapidly progressive neurodegenerative alpha-synucleinopathy in mice. J Exp Med 209: 975-986. CrossRef Medline
33. Luk KC, Kehm V, Carroll J, Zhang B, O'Brien P, Trojanowski JQ, Lee VM (2012) Pathological alpha-synuclein transmission initiates Parkinsonlike neurodegeneration in nontransgenic mice. Science 338: 949-953. CrossRef Medline
34. Maroteaux L, Scheller RH (1991) The rat brain synucleins; family of proteins transiently associated with neuronal membrane. Brain Res Mol Brain Res 11: 335-343. CrossRef Medline
35. Marui W, Iseki E, Nakai T, Miura S, Kato M, Uéda K, Kosaka K (2002) Progression and staging of Lewy pathology in brains from patients with dementia with Lewy bodies. J Neurol Sci 195: 153-159. CrossRef Medline
36. Masliah E, Rockenstein E, Veinbergs I, Mallory M, Hashimoto M, Takeda A, Sagara Y, Sisk A, Mucke L (2000) Dopaminergic loss and inclusion body formation in alpha-synuclein mice: Implications for neurodegenerative disorders. Science 287: 1265-1269. CrossRef Medline
37. Masuda-Suzukake M, Nonaka T, Hosokawa M, Oikawa T, Arai T, Akiyama H, Mann DM, Hasegawa M (2013) Prion-like spreading of pathological alpha-synuclein in brain. Brain 136: 1128-1138. CrossRef Medline
38. Mazza D, Braeckmans K, Cella F, Testa I, Vercauteren D, Demeester J, De Smedt SS, Diaspro A (2008) A new FRAP/FRAPa method for threedimensional diffusion measurements based on multiphoton excitation microscopy. Biophys J 95: 3457-3469. CrossRef Medline
39. Meshul CK, McGinty JF (2000) Kappa opioid receptor immunoreactivity in the nucleus accumbens and caudate-putamen is primarily associated with synaptic vesicles in axons. Neuroscience 96: 91-99. CrossRef Medline
40. Meshul CK, Stallbaumer RK, Taylor B, Janowsky A (1994) Haloperidolinduced morphological changes in striatum are associated with glutamate synapses. Brain Res 648: 181-195. CrossRef Medline
41. Meshul CK, Emre N, Nakamura CM, Allen C, Donohue MK, Buckman JF (1999) Time-dependent changes in striatal glutamate synapses following a 6-hydroxydopamine lesion. Neuroscience 88: 1-16. CrossRef Medline
42. Miake H, Mizusawa H, Iwatsubo T, Hasegawa M (2002) Biochemical characterization of the core structure of alpha-synuclein filaments. J Biol Chem 277: 19213-19219. CrossRef Medline
43. Mueller F, Morisaki T, Mazza D, McNally JG (2012) Minimizing the impact of photoswitching of fluorescent proteins on FRAP analysis. Biophys J 102: 1656-1665. CrossRef Medline
44. Murray TA, Levene MJ (2012) Singlet gradient index lens for deep in vivo multiphoton microscopy. J Biomed Opt 17: 021106. CrossRef Medline
45. Nakamura K, Nemani VM, Azarbal F, Skibinski G, Levy JM, Egami K, Munishkina L, Zhang J, Gardner B, Wakabayashi J, Sesaki H, Cheng Y, Finkbeiner S, Nussbaum RL, Masliah E, Edwards RH (2011) Direct membrane association drives mitochondrial fission by the Parkinson disease-associated protein alpha-synuclein. J Biol Chem 286: 20710-20726. CrossRef Medline
46. Nemani VM, Lu W, Berge V, Nakamura K, Onoa B, Lee MK, Chaudhry FA, Nicoll RA, Edwards RH (2010) Increased expression of alpha-synuclein reduces neurotransmitter release by inhibiting synaptic vesicle reclustering after endocytosis. Neuron 65: 66-79. CrossRef Medline
47. Neumann M, Kahle PJ, Giasson BI, Ozmen L, Borroni E, Spooren W, Müller V, Odoy S, Fujiwara H, Hasegawa M, Iwatsubo T, Trojanowski JQ, Kretzschmar HA, Haass C (2002) Misfolded proteinase K-resistant hyperphosphorylated alpha-synuclein in aged transgenic mice with locomotor deterioration and in human alpha-synucleinopathies. J Clin Invest 110: 1429-1439. CrossRef Medline
48. Norris EH, Giasson BI, Lee VM (2004) Alpha-synuclein: Normal function and role in neurodegenerative diseases. Curr Top Dev Biol 60: 17-54. CrossRef Medline
49. Oueslati A, Schneider BL, Aebischer P, Lashuel HA (2013) Polo-like kinase 2 regulates selective autophagic alpha-synuclein clearance and suppresses its toxicity in vivo. Proc Natl Acad Sci U S A 110: E3945-E3954. CrossRef Medline
50. Outeiro TF, Putcha P, Tetzlaff JE, Spoelgen R, Koker M, Carvalho F, Hyman BT, McLean PJ (2008) Formation of toxic oligomeric alpha-synuclein species in living cells. PLoS One 3: e1867. CrossRef Medline
51. Phend KD, Weinberg RJ, Rustioni A (1992) Techniques to optimize postembedding single and double staining for amino acid neurotransmitters. J Histochem Cytochem 40: 1011-1020. CrossRef Medline
52. Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, Pike B, Root H, Rubenstein J, Boyer R, Stenroos ES, Chandrasekharappa S, Athanassiadou A, Papapetropoulos T, Johnson WG, Lazzarini AM, Duvoisin RC, Di Iorio G, Golbe LI, Nussbaum RL (1997) Mutation in the alphasynuclein gene identified in families with Parkinson's disease. Science 276: 2045-2047. CrossRef Medline
53. Rieker C, Dev KK, Lehnhoff K, Barbieri S, Ksiazek I, Kauffmann S, Danner S, Schell H, Boden C, Ruegg MA, Kahle PJ, van der Putten H, Shimshek DR (2011) Neuropathology in mice expressing mouse alpha-synuclein. PLoS One 6: e24834. CrossRef Medline
54. Rizo J, Sudhof TC (2012) The membrane fusion enigma: SNARES, Sec/ Munc18 proteins, and their accomplices-guilty as charged? Annu Rev Cell Dev Biol 28: 279-303. CrossRef Medline
55. Roberti MJ, Jovin TM, Jares-Erijman E (2011) Confocal fluorescence anisotropy and FRAP imaging of alpha-synuclein amyloid aggregates in living cells. PLoS One 6: e23338. CrossRef Medline
56. Rockenstein E, Schwach G, Ingolic E, Adame A, Crews L, Mante M, Pfragner R, Schreiner E, Windisch M, Masliah E (2005) Lysosomal pathology associated with alpha-synuclein accumulation in transgenic models using an eGFP fusion protein. J Neurosci Res 80: 247-259. CrossRef Medline
57. Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, Preibisch S, Rueden C, Saalfeld S, Schmid B, Tinevez JY, White DJ, Hartenstein V, Eliceiri K, Tomancak P, Cardona A (2012) Fiji: An opensource platform for biological-image analysis. Nat Methods 9: 676-682. CrossRef Medline
58. Schmidt H, Arendt O, Brown EB, Schwaller B, Eilers J (2007) Parvalbumin is freely mobile in axons, somata and nuclei of cerebellar purkinje neurones. J Neurochem 100: 727-735. CrossRef Medline
59. Schnell EA, Eikenes L, Tufto I, Erikson A, Juthajan A, Lindgren M, de Lange Davies C (2008) Diffusion measured by fluorescence recovery after photobleaching based on multiphoton excitation laser scanning microscopy. J Biomed Opt 13: 064037. CrossRef Medline
60. Scott D, Roy S (2012) Alpha-synuclein inhibits intersynaptic vesicle mobility and maintains recycling-pool homeostasis. J Neurosci 32: 10129-10135. CrossRef Medline
61. Scott DA, Tabarean I, Tang Y, Cartier A, Masliah E, Roy S (2010) A pathologic cascade leading to synaptic dysfunction in alpha-synuclein-induced neurodegeneration. J Neurosci 30: 8083-8095. CrossRef Medline
62. Shibayama-Imazu T, Okahashi I, Omata K, Nakajo S, Ochiai H, Nakai Y, Hama T, Nakamura Y, Nakaya K (1993) Cell and tissue distribution and developmental change of neuron specific 14 kDa protein (phosphoneuroprotein 14). Brain Res 622: 17-25. CrossRef Medline
63. Singleton AB, Farrer M, Johnson J, Singleton A, Hague S, Kachergus J, Hulihan M, Peuralinna T, Dutra A, Nussbaum R, Lincoln S, Crawley A, Hanson M, Maraganore D, Adler C, Cookson MR, Muenter M, Baptista M, Miller D, Blancato J, Hardy J, Gwinn-Hardy K (2003) Alpha-synuclein locus triplication causes Parkinson's disease. Science 302: 841. CrossRef Medline
64. Sone M, Yoshida M, Hashizume Y, Hishikawa N, Sobue G (2005) Alphasynuclein-immunoreactive structure formation is enhanced in sympathetic ganglia of patients with multiple system atrophy. Acta Neuropathol 110: 19-26. CrossRef Medline
65. Sprague BL, Pego RL, Stavreva DA, McNally JG (2004) Analysis of binding reactions by fluorescence recovery after photobleaching. Biophys J 86: 3473-3495. CrossRef Medline
66. Sullivan KD, Brown EB (2010) Measuring diffusion coefficients via twophoton fluorescence recovery after photobleaching. J Vis Exp 36: pii: 1636. CrossRef Medline
67. Swaminathan R, Hoang CP, Verkman AS (1997) Photobleaching recovery and anisotropy decay of green fluorescent protein GFP-S65T in solution and cells: Cytoplasmic viscosity probed by green fluorescent protein translational and rotational diffusion. Biophys J 72: 1900-1907. CrossRef Medline
68. Takeda A, Hashimoto M, Mallory M, Sundsumo M, Hansen L, Sisk A, Masliah E (1998) Abnormal distribution of the non-abeta component of alzheimer's disease amyloid precursor/alpha-synuclein in Lewy body disease as revealed by proteinase K and formic acid pretreatment. Lab Invest 78: 1169-1177. Medline
69. Tanji K, Mori F, Mimura J, Itoh K, Kakita A, Takahashi H, Wakabayashi K (2010) proteinase K-resistant alpha-synuclein is deposited in presynapses in human Lewy body disease and A53T alpha-synuclein transgenic mice. Acta Neuropathol 120: 145-154. CrossRef Medline
70. Tofaris GK, Spillantini MG (2005) Alpha-synuclein dysfunction in Lewy body diseases. Mov Disord 20: S37-S44. CrossRef Medline
71. Unni VK, Weissman TA, Rockenstein E, Masliah E, McLean PJ, Hyman BT (2010) In vivo imaging of alpha-synuclein in mouse cortex demonstrates stable expression and differential subcellular compartment mobility. PLoS One 5: e10589. CrossRef Medline
72. Uversky VN, Li J, Fink AL (2001) Pesticides directly accelerate the rate of alpha-synuclein fibril formation: A possible factor in Parkinson's disease. FEBS Lett 500: 105-108. CrossRef Medline
73. van Ham TJ, Thijssen KL, Breitling R, Hofstra RM, Plasterk RH, Nollen EA (2008) C. elegans model identifies genetic modifiers of alpha-synuclein inclusion formation during aging. PLoS Genet 4: e1000027. CrossRef Medline
74. Walker RH, Moore C, Davies G, Dirling LB, Koch RJ, Meshul CK (2012) Effects of subthalamic nucleus lesions and stimulation upon corticostriatal afferents in the 6-hydroxydopamine-lesioned rat. PLoS One 7: e32919. CrossRef Medline
75. Wislet-Gendebien S, D'Souza C, Kawarai T, St George-Hyslop P, Westaway D, Fraser P, Tandon A (2006) Cytosolic proteins regulate alphasynuclein dissociation from presynaptic membranes. J Biol Chem 281: 32148-32155. CrossRef Medline
76. Wislet-Gendebien S, Visanji NP, Whitehead SN, Marsilio D, Hou W, Figeys D, Fraser PE, Bennett SA, Tandon A (2008) Differential regulation of wild-type and mutant alpha-synuclein binding to synaptic membranes by cytosolic factors. BMC Neurosci 9: 92. CrossRef Medline
77. Yasuda T, Nakata Y, Choong CJ, Mochizuki H (2013) Neurodegenerative changes initiated by presynaptic dysfunction. Transl Neurodegener 2: 16. CrossRef Medline
78. Yokoe H, Meyer T (1996) Spatial dynamics of GFP-tagged proteins investigated by local fluorescence enhancement. Nat Biotechnol 14: 1252-1256. CrossRef Medline
79. Zach S, Bueler H, Hengerer B, Gillardon F (2007) Predominant neuritic pathology induced by viral overexpression of alpha-synuclein in cell culture. Cell Mol Neurobiol 27: 505-515. CrossRef Medline
80. Zarranz JJ, Alegre J, Gómez-Esteban JC, Lezcano E, Ros R, Ampuero I, Vidal L, Hoenicka J, Rodriguez O, Atarés B, Llorens V, Gómez Tortosa E, del Ser T, Muñoz DG, de Yebenes JG (2004) The new mutation, E46K, of alphasynuclein causes Parkinson and Lewy body dementia. Ann Neurol 55: 164-173. CrossRef Medline